Frontiers in Neurology, 2024 · DOI: 10.3389/fneur.2024.1430288 · Published: November 11, 2024
Pathological neuropathic pain is a frequent complication following spinal cord injury, marked by its persistence and resistance to treatment. Current treatments include medications like analgesics, anticonvulsants, and antidepressants, which often provide inadequate relief or cause severe side effects. Emerging strategies combine pharmacological and non-pharmacological approaches to improve pain management. The underlying mechanisms of neuropathic pain after spinal cord injury are complex, involving structural and functional changes in the nervous system, pain signal transmission, and inflammation. This complexity presents significant challenges to effective clinical management and necessitates a multifaceted approach to treatment. This review provides a comprehensive overview of existing literature, examining both the mechanisms and clinical interventions for pathological neuropathic pain following spinal cord injury. It aims to offer new insights for basic science research and improve clinical practices in the treatment of spinal cord injuries.
Given the intricate mechanisms underlying NP after SCI, individualized treatment plans tailored to each patient’s unique condition are essential for optimal outcomes.
Achieving optimal outcomes likely involves a combination of various treatment modalities, integrating pharmacological, non-pharmacological, and emerging therapies.
Continued research into the role of gut microbiota, mental imagery, and nanomedicine holds promise for developing new and more effective treatments for NP following SCI.